glp-1 receptor agonist and dpp-4 inhibitor combination contraindicated versus kidney and cardiovascular outcomes in clinical practice in type-2 diabetes Table 2 from DPP- 4
Description
In this review we have explored the link between GLP-1, inflammation, and sepsis
doi: 10.1053/j.gastro.2018.09.021
Scheme 8
Vascular biology of glucagon receptor superfamily peptides: mechanistic and clinical relevance
First submitted to a journal in 1989, the article was finally published in 1992
A massive adoption of GLP-1 drugs in leading markets and growth areas (notably Asian markets) could be a significant blow to many food companies
